Montana Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -72.49%
(FY 2023)
- Profit -76.05%
(FY 2023)
- Ebitda 1095.17%
(FY 2023)
- Net Worth 8.48%
(FY 2023)
- Total Assets -7.00%
(FY 2023)
About Montana Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Munish Dhilon, Viejay Singla, and Anubha Agarwal serve as directors at the Company.
- CIN/LLPIN
U24100DL2015PTC280530
- Company No.
280530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Montana Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Dhilon  | Director | 20-May-2015 | Current |
| Viejay Singla | Additional Director | 05-Oct-2020 | Current |
| Anubha Agarwal | Director | 18-Nov-2021 | Current |
Financial Performance of Montana Remedies.
Montana Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 72.49% decrease. The company also saw a substantial fall in profitability, with a 76.05% decrease in profit. The company's net worth moved up by a moderate rise of 8.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Montana Remedies?
Unlock access to Montana Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Tirath Singh & Bros Agencies Private LimitedActive 3 years 10 months
Viejay Singla is a mutual person
- Singlamedicos Pharma Solutions Private LimitedActive 2 years 9 months
Viejay Singla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Montana Remedies?
Montana Remedies has a workforce of 7 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Montana Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Montana Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
